Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Another Botox Competitor: Revance Prepares Longer-Lasting RT002 For BLA Submission

Clinic of Aesthetic Medicine. Botox / Disport Procedure for men.

Related Content

Mapping US FDA's Biosimilar Pathway With Pink Sheet Drug Review Profiles

Jul 26 2017

Mylan has biosimilar aspirations for Botox

Mar 09 2018

With Jeuveau Approval, Evolus Will Focus On The Beauty Business To Gain Market Share

Feb 05 2019

Merz Neurology Business Boosted By Xeomin Sialorrhea OK

Jul 05 2018

Related Companies

Revance Therapeutics, Inc.

Allergan plc

Viatris Inc.

Merz Pharmaceuticals GmbH

Ipsen SA

Evolus, Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Additional Topics

Business Strategies Biosimilars Companies Commercial Aesthetics BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window